Skip to main content
Figure 5 | BMC Cancer

Figure 5

From: Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study

Figure 5

Trough blood concentrations of vinorelbine over time. Scatter plots of serial trough concentrations of VLR and its active metabolite DVLR over time in a patient prostate cancer patient treated at 50 mg dose arm (A) and a breast cancer patient treated at 40 mg (B) and median (plus SEM) values of steady state levels of all patients treated at the three dose arms (C).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us